- 专利标题： BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20
-
申请号： US18623246申请日： 2024-04-01
-
公开(公告)号： US20240261334A1公开(公告)日： 2024-08-08
- 发明人: Yvonne Y. Chen , Eugenia Zah , Michael C. Jensen
- 申请人： The Regents of the University of California , Seattle Children's Hospital DBA Seattle Children's Research Institute
- 申请人地址： US CA Oakland
- 专利权人： The Regents of the University of California,Seattle Children's Hospital DBA Seattle Children's Research Institute
- 当前专利权人： The Regents of the University of California,Seattle Children's Hospital DBA Seattle Children's Research Institute
- 当前专利权人地址： US CA Oakland
- 主分类号： A61K35/17
- IPC分类号： A61K35/17 ; A61K38/00 ; A61K39/00 ; C07K14/705 ; C07K14/725 ; C07K16/28 ; C07K16/46 ; C12N5/0783
摘要：
A CD19-OR-CD20 chimeric antigen receptor (CAR) protein construct is provided. Also provided are nucleic acids encoding the CD19-OR-CD20 CAR; and methods of use, e.g. in the treatment of B cell malignancies. The CD19-OR-CD20 CAR of the invention is a bispecific CAR that can trigger T-cell activation upon detection of either CD19 or CD20 (or both). It is a single molecule that confers two-input recognition capability upon human T cells engineered to stably express this CAR.
信息查询
IPC分类:
